Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FES PET/CT for Axillary Lymph Node Metastasis in Invasive Lobular Carcinoma
NCT05960201Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoroestradiol f 18 in invasive lobular carcinoma (ILC), sponsored by Asan Medical Center. Started Aug 2023; status: completed.
02
Drugs
fluoroestradiol f 18
03
Conditions
invasive lobular carcinoma (ILC)
Beyond the preview
Go deeper on NCT05960201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960201.